Evidence map›Paper›PMID 40097865›Full record

ArticleJournal of clinical immunology2025

Deficiency of Adenosine Deaminase 2 Masquerading as Behçet's Disease: Phenotypic Mimicry with HLA-B*51 Positivity.

Abdullah Almojali, Abdulrahman Alrasheed, Bushra Alharbi, Reem Alharbi, Wafaa Alsuwairi, Fayhan Alroqi, Jubran Alqanatish

Abstract readCase Reports
In one paragraph

Article in Journal of clinical immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Abdullah AlmojaliDivision of Pediatric Rheumatology, Department of Pediatrics, King Abdullah Specialized Children'S Hospital, King Abdulaziz Medical City, 14611, Riyadh, Saudi Arabia. AbdullahAlmojali@gmail.com.ORCID http://orcid.org/0000-0003-4208-4196
Abdulrahman AlrasheedDivision of Pediatric Rheumatology, Department of Pediatrics, King Abdullah Specialized Children'S Hospital, King Abdulaziz Medical City, 14611, Riyadh, Saudi Arabia. Alrasheedab6@mngha.med.sa.ORCID http://orcid.org/0000-0001-9626-1931
Bushra AlharbiKing Abdullah International Medical Research Center (KAIMRC), 14611, Riyadh, Saudi Arabia.ORCID http://orcid.org/0009-0004-7196-7267
Reem AlharbiKing Abdullah International Medical Research Center (KAIMRC), 14611, Riyadh, Saudi Arabia.ORCID http://orcid.org/0000-0003-3888-7850
Wafaa AlsuwairiDivision of Pediatric Rheumatology, Department of Pediatrics, King Abdullah Specialized Children'S Hospital, King Abdulaziz Medical City, 14611, Riyadh, Saudi Arabia.ORCID http://orcid.org/0009-0002-2477-1021
Fayhan AlroqiKing Abdullah International Medical Research Center (KAIMRC), 14611, Riyadh, Saudi Arabia.ORCID http://orcid.org/0000-0001-5271-0002
Jubran AlqanatishDivision of Pediatric Rheumatology, Department of Pediatrics, King Abdullah Specialized Children'S Hospital, King Abdulaziz Medical City, 14611, Riyadh, Saudi Arabia.ORCID http://orcid.org/0000-0001-6467-6972

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeDeficiency of adenosine deaminase 2 (DADA2) is a rare monogenic autoinflammatory disease resulting from biallelic loss-of-function mutations in ADA2 gene. It has variable clinical manifestations, some of which can mimic Behçet's disease (BD). Herein, we present a family of three siblings diagnosed with DADA2, two of whom were initially misdiagnosed as BD based on clinical phenotype including positive human leukocyte antigen B51 (HLA-B*51).

methodsGene mutational analysis was performed by whole exome (WES) and Sanger sequencing.

resultsWe reported two siblings presented with recurrent oral ulcers, fever, arthritis, and skin lesions, alongside elevated inflammatory markers and HLA-B*51 positivity, leading to an initial misdiagnosis of BD. Genetic testing later revealed a homozygous ADA2 variant (c.139G > A p.Gly47Arg) in both siblings and their asymptomatic younger sister, confirming DADA2 diagnosis. Thereafter, we reviewed the literature to identify other patients misdiagnosed with BD but later found to have DADA2. This resulted in a cohort of 10 DADA2 patients, including our two reported siblings. The median time from symptoms onset to the final diagnosis of DADA2 was 7 years. All patients exhibited BD-like phenotype, except for uveitis, and 8 were HLA-B*51 positive, which likely contributed to the diagnostic confusion.

conclusionThese findings highlight the broad clinical spectrum of DADA2, which can resemble BD, and suggest that HLA-B*51 positivity in DADA2 may further complicate diagnosis. Clinicians should maintain a high index of suspicion for DADA2 in early-onset BD-like cases, particularly without uveitis, or a family history of similar symptoms. Further studies are warranted to explore HLA-B*51 role in DADA2 phenotype.

Indexed as

Adenosine DeaminaseBehcet SyndromeHLA-B51 AntigenIntercellular Signaling Peptides and ProteinsDiagnosis, DifferentialHereditary Autoinflammatory DiseasesHumansMutationPedigreePhenotypeSiblingsADA2 protein, humanAdenosine DeaminaseHLA-B51 AntigenIntercellular Signaling Peptides and ProteinsADA2 deficiencyAutoinflammatoryBehçet’s diseaseChildrenHLA-B*51Rheumatic disease

Identifiers

PMID40097865
PMCPMC11913947

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.